MBOT
Microbot Medical Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.36
−4.23%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-25.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 3, 2026 | Burell Scott R · director | A-Award | 10,000 | $2.37 |
| Apr 3, 2026 | Madden Martin J. · director | A-Award | 10,000 | $2.37 |
| Apr 3, 2026 | Stockburger Aileen Ptucha · director | A-Award | 10,000 | $2.37 |
| Apr 3, 2026 | Wilson David James · director | A-Award | 10,000 | $2.37 |
| Apr 3, 2026 | Wenderow Tal Baruch · director | A-Award | 10,000 | $2.37 |
| Apr 3, 2026 | Laxminarain Prattipati · director | A-Award | 10,000 | $2.37 |
| Feb 20, 2026 | Gadot Harel · director, officer: Chairman, President and CEO | A-Award | 480,000 | $2.10 |
| Feb 20, 2026 | Sharon Simon · officer: General Manager, CTO | A-Award | 105,000 | $2.10 |
| Feb 20, 2026 | Vaknin Rachel · officer: Chief Financial Officer | A-Award | 105,000 | $2.10 |
| Feb 20, 2026 | Diaz-Cartelle Juan · officer: Chief Medical Officer | A-Award | 105,000 | $2.10 |
| Feb 7, 2025 | Diaz-Cartelle Juan · officer: Chief Medical Officer | A-Award | 10,500 | $1.25 |
| Feb 7, 2025 | Vaknin Rachel · officer: Chief Financial Officer | A-Award | 4,375 | $1.25 |
| Feb 7, 2025 | Sharon Simon · officer: General Manager, CTO | A-Award | 43,750 | $2.04 |
| Feb 7, 2025 | Gadot Harel · director, officer: Chairman, President and CEO | A-Award | 12,000 | $1.25 |
| Feb 7, 2025 | Sharon Simon · officer: General Manager, CTO | A-Award | 8,750 | $1.25 |
| Feb 7, 2025 | Diaz-Cartelle Juan · officer: Chief Medical Officer | A-Award | 42,000 | $2.04 |
| Feb 7, 2025 | Vaknin Rachel · officer: Chief Financial Officer | A-Award | 48,125 | $2.04 |
| Feb 7, 2025 | Gadot Harel · director, officer: Chairman, President and CEO | A-Award | 228,000 | $2.04 |
| Jan 30, 2025 | Wenderow Tal Baruch · director | A-Award | 10,000 | $1.93 |
| Jan 30, 2025 | Burell Scott R · director | A-Award | 10,000 | $1.93 |
| Jan 30, 2025 | Madden Martin J. · director | A-Award | 10,000 | $1.93 |
| Jan 30, 2025 | Laxminarain Prattipati · director | A-Award | 10,000 | $1.93 |
| Jan 30, 2025 | Stockburger Aileen Ptucha · director | A-Award | 10,000 | $1.93 |
| Jan 30, 2025 | Wilson David James · director | A-Award | 20,000 | $1.93 |
| Feb 26, 2024 | Gadot Harel · director, officer: Chairman, President and CEO | A-Award | 79,567 | $1.25 |
| Feb 26, 2024 | Gadot Harel · director, officer: Chairman, President and CEO | A-Award | 80,000 | $1.27 |
| Feb 26, 2024 | Vaknin Rachel · officer: Chief Financial Officer | A-Award | 17,500 | $1.27 |
| Feb 26, 2024 | Sharon Simon · officer: General Manager, CTO | A-Award | 17,500 | $1.27 |
| Feb 26, 2024 | Diaz-Cartelle Juan · officer: Chief Medical Officer | A-Award | 17,500 | $1.27 |
| Nov 6, 2023 | Madden Martin J. · director | A-Award | 74,218 | $1.28 |
Institutional positioning
13F filings over the trailing two quarters
New 34Increased 48Reduced 31Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,909,525 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 2,906,810 | Aug 13, 2026 |
| CIBC Bancorp USA Inc. | New Position | 1,870,000 | May 12, 2026 |
| Mitsubishi UFJ Asset Management Co., Ltd. | New Position | 1,268,453 | Aug 7, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 1,140,707 | May 15, 2026 |
| BlackRock, Inc. | Increased | 902,411 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 857,398 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 836,271 | Aug 12, 2026 |
| UBS GROUP AG | Increased | 816,945 | May 5, 2026 |
| UBS Group AG | Reduced | 806,847 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 760,831 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 736,827 | Aug 14, 2026 |
| DnB Asset Management AS | Unchanged | 677,498 | Aug 11, 2026 |
| DNB ASSET MANAGEMENT AS | Unchanged | 677,498 | May 14, 2026 |
| STIFEL FINANCIAL CORP | Increased | 589,924 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 3, 2026